RAD51 and pancreatic neoplasm: BBR showed inhibitory effects in pancreatic cancer cells (PANC-1, AsPC-1, and MIA-PaCa-2) on the expression of Rad51 and the upregulation of PARP expression compared with control pancreatic cancer cells.